巨子生物盘中涨超4% 获多家大行调升目标价

新浪网
31 Mar

巨子生物盘中涨超4%,截至发稿,股价上涨2.06%,现报69.40港元,成交额2.75亿港元。巨子生物近期发布2024年度业绩,该集团期内取得收入55.39亿元(人民币,下同),同比增加57.2%;归属于母公司持有者盈利20.62亿元,同比增加42.1%;每股基本盈利2.1元;拟派发末期股息每股0.6021元及特别股息每股0.5921元。汇丰研究发表报告指,巨子生物2024年财报表现强劲,符合该行...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10